Fresenius Medical Care announced today that it received a positive rating for its efforts in climate protection. According to a news release, the company garnered a “B” rating from the nonprofit organization CDP, marking its place in the second-highest categories. Fresenius said it received a “B” in the climate area and a “B–” in the […]
Fresenius
Fresenius Medical Care investing $25M in Humacyte as it goes public in SPAC deal
Fresenius Medical Care announced today that it will invest $25 million in Humacyte in connection with the merger of Humacyte and a SPAC. Humacyte, which develops implantable human acellular vessels for multiple vascular repair, reconstruction and replacement, entered into a merger with a special purpose acquisition company (SPAC), leading Fresenius to increase its position in […]
Fresenius to provide more home dialysis machines to DaVita
Fresenius Medical Care North America (FMCNA) has expanded its agreement with DaVita Kidney Care to provide NxStage home hemodialysis machines and related technology to DaVita’s U.S. patients. “We are excited to expand our longstanding collaboration with DaVita to help more patients benefit from the portability, dependability, and flexibility of our NxStage home machines, which are […]
Diversity in medtech: Just 20% of executive roles held by women
Diversity in executive roles in the medical device industry is trending more toward parity, with women holding 2% more C-suite roles in 2020 compared to last year. Just 20% of executives at the 100 largest medical device companies in the world are women, and those companies average 19% female composition in the C-suite, according to […]
Fresenius to enter heart, lung, organ failure markets
Fresenius Medical Care (NYSE:FMS) announced today that its new growth strategy includes treating heart, lung and multi-organ failure. Hamburg, Germany-based Fresenius’ strategy centers around three major areas: renal care, critical care solutions and complementary assets, according to a news release. The company’s renal care continuum is to be bolstered by artificial intelligence and data analysis technologies […]
FDA issues EUA for Sterilucent N95 hydrogen peroxide sterilization
The FDA has granted Sterilucent emergency use authorization (EUA) for its hydrogen peroxide sterilizer for use with N95 and N95-equivalent respirators — the latest in a string of mask sterilizers receiving EUAs amid the coronavirus pandemic. Minneapolis-based Sterilucent’s HC 80TT vaporized hydrogen peroxide sterilizer may now be used to decontaminate the single-use compatible respirators that […]
Latest pandemic-related shortages: Dialysis machines & supplies
Medtech manufacturers have begun responding to some unexpected shortages brought on by the coronavirus pandemic. Demand for kidney dialysis equipment and supplies has jumped in hospitals in COVID-19 hot spots, leading to spot shortages and taking healthcare providers by surprise, as they considered the virus a respiratory disease. Get the full story on our sister […]
Fresenius to launch a mechanical ventilators alternative in U.S.
Fresenius (NYSE:FMS) announced today that it has achieved a 510(k) clearance for its Novalung system — which reduces or eliminates the need for mechanical ventilation by pumping a person’s blood through an oxygenator for gas exchange. Fresenius boasted that the Novalung is the first extracorporeal membrane oxygenation (ECMO) system cleared to provide more than six hours […]
Fresenius Medical Care North America launches connected health platform
Fresenius (NYSE:FMS) recently announced that its Fresenius Medical Care North America (FMCNA) business has launched a connected health platform called TheHub. TheHub includes three integrated applications meant to enable people on dialysis, their care teams, and health providers to better collaborate. Fresenius officials see the system enhancing remote monitoring for people on home dialysis. The Trump administration […]
Fresenius Medical Care wins FDA breakthrough nod for clot-preventing dialysis device
Fresenius Medical Care North America (NYSE:FMS) said today that it won breakthrough device designation from the FDA for the new hemodialysis system it’s developing. Waltham, Mass.-based Fresenius said its Endexo antithrombogenic additive is being incorporated into the manufacturing of dialyzers and bloodlines. The device is a polymer made of modifying molecules designed to inhibit the adsorption […]
Report: Fresenius to shutter Ohio billing operation, lay off 57
Fresenius Management Services (NYSE:FMS; ETR:FRE) is reportedly closing its medical billing facility and laying off nearly 60 employees in North Olmsted, Ohio. The company filed a Worker Adjustment and Retraining Notification on Oct. 4 saying that it would lay off 56 employees on December 6 and add one more employee to the layoffs on Jan. […]